Selcia joins Eurofins Group

26-Jan-2018 - Selcia Limited announces that it has been acquired by Eurofins Scientific, a global leader in analytical testing and pharma discovery services. The acquisition of Selcia provides Eurofins with an entry into the custom radiolabelling and innovative pre-clinical, integrated drug discovery services ...

Seeing more with PET scans

New chemistry for medical imaging

28-Jul-2017 - Researchers have found a surprisingly versatile workaround to create chemical compounds that could prove useful for medical imaging and drug development. The chemical mechanism, discovered by scientists at the Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) and UC ...

State-of-the-art text mining technologies for chemistry

23-Jun-2017 - The Biological Text Mining Unit at the Spanish National Cancer Research Centre (CNIO) together with with researchers at the Center for Applied Medical Research (CIMA), of the University of Navarra, in Pamplona, and the Barcelona Supercomputing Centre (BSC-CNS) have published the first exhaustive ...

Evotec Signs High Throughput Screening Agreement with Active Biotech

15-Mar-2010 - Evotec AG announced that it has entered into a collaboration with Active Biotech AB to identify small molecule modulators of a priority biological target, selected by Active Biotech, involved in immune disorders and cancer. Evotec will use its expertise and technologies in assay development, ...

Link Technologies secures exclusive license for ultra sensitive diagnostic probes

Deal marks the start of ongoing collaboration between Link and The University of Manchester

01-Dec-2009 - Link Technologies Ltd has announced an exclusive license deal with The University of Manchester Intellectual Property Limited (UMIP). Under the terms of the license for the University’s “exciplex” technology, Link will manufacture and sell highly sensitive exciplex-based diagnostic reagents ...

A potential new imaging agent for early diagnosis of most serious skin cancer

05-Oct-2009 - Scientists in Australia are reporting development and testing in laboratory animals of a potential new material for diagnosing malignant melanoma, the most serious form of skin cancer. Their study is scheduled for ACS' Journal of the Medicinal Chemistry. Ivan Greguric and colleagues working ...

Adding genetics to a patient's clinical profile might lead to more accurate blood-thinner dosing

23-Feb-2009 - Including genetic information in a patient's clinical profile might help determine the optimal starting dose of the common blood-thinner warfarin, according to findings from a large-scale study that will be published in the New England Journal of Medicine. Researchers from more than 20 ...

AMRI Names Senior Director, Analytical and Quality Services

14-Jan-2009 - AMRI announced that Junan Guo, Ph.D. has joined the company as senior director, analytical and quality services. Dr. Guo fills the role vacated by Dr. Steven Hagen, who was promoted to vice president of pharmaceutical development and manufacturing in September 2008. Dr. Guo will oversee all ...

Evotec to Launch its First Innovation Centre for Fragment Based Drug Discovery

24-May-2007 - Evotec AG announced the launch of its Innovation Centre for Fragment Based Drug Discovery ('FBDD'). FBDD offers an alternative approach for identifying novel, small molecule hits (fragments) for a number of biological targets including those that have proved problematic using traditional drug ...

Galapagos expands and extends drug discovery collaboration with Amgen into 2008

04-Jan-2007 - Galapagos NV announced that its service division BioFocus DPI has expanded and extended its longstanding drug discovery collaboration with Amgen through 2007 and 2008. BioFocus DPI will continue to provide biology, computational and medicinal chemistry services and will supply ...